RAAS TRIPLE-A
Live / Registered — Registered (as of 25 Feb 2020)
What this means for you
Registered since 25 Feb 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79256903
- Registration number
- 5993170
- Mark type
- Stylized text
- Filed
- 19 Dec 2018
- Published for opposition
- 10 Dec 2019
- Registered
- 25 Feb 2020
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 001 — Chemicals: Chemical, biochemical and biotechnological products, namely, chemical, biochemical and biotechnological agents used for non-medical purposes, namely, agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; chemical preparations, namely, chemical preparations for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; biochemical agents, namely, biochemical agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; buffers, namely, buffers for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system
- Class 005 — Pharmaceuticals: Diagnostic agents for pharmaceutical purposes containing chemical preparations, biochemical agents, buffers, and diagnostic reagents, also in the form of kits, for medical purposes in the field of treating diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
- Class 009 — Scientific and electric apparatus: Downloadable computer software, application software, mobile application software, software development tools in the nature of computer software, database software in the nature of computer software for use in database management, all aforementioned goods downloadable and related to the medical field, namely, for researching diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
- Class 042 — Scientific and technological services: Medical and scientific research and analysis services in the nature of quality measurement and analysis for medical practices, and software design and development concerning quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system in the field of researching, diagnosing, preventing, combating, treating, and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
- Class 044 — Medical, beauty and agricultural services: Medical services, medical care, medical testing in the nature of medical diagnostic testing; providing information in the field of medical information, namely, in the fields of diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
Owner
Prosecution history
- 24 Feb 2026 — TEAS SECTION 71 RECEIVED
- 25 Feb 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 04 Nov 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 26 Nov 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 17 Jul 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 25 Jun 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 25 Jun 2020 — FINAL DISPOSITION PROCESSED
- 25 May 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 25 Feb 2020 — REGISTERED-PRINCIPAL REGISTER
- 10 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2019 — PUBLISHED FOR OPPOSITION
- 20 Nov 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Nov 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Nov 2019 — EXAMINER'S AMENDMENT ENTERED
- 03 Nov 2019 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED